Common questions about Lovaza (FAQ)
Q: What is the difference between Lovaza and regular fish oil supplements?
A: Lovaza is a prescription-only medication that is approved by the FDA to treat severe hypertriglyceridemia. Unlike general over-the-counter supplements, it contains a high, standardized concentration of the active ingredients. This processing brings the medicine to a pharmaceutical-grade standard, which distinguishes it from general fish oil products.
Q: Why did my doctor prescribe Lovaza instead of just recommending diet changes?
A: Official product information states that Lovaza is used as an adjunct to diet for the chronic management of severe hypertriglyceridemia (triglyceride levels ge 500 mg/dL). This indicates that Lovaza is used when diet alone may not sufficiently manage severe hypertriglyceridemia, and the medication works alongside diet to help reduce blood fat levels.
Q: How long does it typically take to see an effect from Lovaza?
A: Studies that evaluated the change in blood lipids primarily examined results over short-to-intermediate periods, typically ranging from 6 to 16 weeks. This research timeframe reflects the period over which changes in triglyceride levels were measured in clinical studies, rather than a guarantee of a specific personal result.
Q: Do I need to keep taking Lovaza even after my blood tests improve?
A: The official prescribing information indicates that Lovaza is generally intended for long-term use as part of a chronic management plan. This approach is consistent with the drug’s labeling as a chronic treatment, supporting the maintenance of managed triglyceride levels over a longer period.
Q: Are there any restrictions on Lovaza use for older adults?
A: Regulatory data indicates that studies performed to date have not demonstrated geriatric-specific problems that would generally limit the usefulness of Lovaza in older adults. Use in older adults still warrants standard medical supervision and monitoring, consistent with any chronic therapy.
Q: What happens if I accidentally miss a dose of Lovaza?
A: The official patient information provides specific instructions for handling a missed dose. These instructions clarify when to take the dose and when it is necessary to skip it, and state that a double or extra dose should not be taken.
Q: Does the manufacturing process of Lovaza remove potential contaminants?
A: Official product descriptions note that Lovaza is derived from fish oil that undergoes extensive purification to meet a pharmaceutical-grade standard. This specialized purification process achieves a high pharmaceutical-grade standard by reducing environmental pollutants and contaminants.
Q: Can Lovaza affect my blood sugar levels?
A: While affecting blood sugar is not listed as a common side effect in regulatory documents, official text advises that medical problems such as diabetes mellitus should be identified and controlled before starting therapy. This reflects the need to manage all underlying conditions that may be contributing to the elevated triglyceride levels being addressed by the medication.
Q: Does Lovaza interact with common pain relievers like ibuprofen?
A: Regulatory information advises caution when using Lovaza alongside other medicines that affect blood clotting, such as anti-platelet agents (a class that includes some common pain relievers). This caution is advised because Lovaza itself may contribute to a prolonged bleeding time.
Q: What should I tell my dentist or surgeon if I am taking Lovaza?
A: It is recommended to inform all healthcare providers, including surgeons and dentists, that you are taking Lovaza. This medication may contribute to prolonged bleeding time when used with other agents that affect coagulation. This information is relevant for healthcare providers when considering any procedure where bleeding risk is a factor.
Q: Is it common to have blood work done frequently while on Lovaza?
A: Official documents indicate that patients should have blood tests performed periodically during therapy. These tests are used to monitor the various lipid and cholesterol levels, as well as the patient's status while on treatment. Liver enzyme levels ( ALT and AST) are tracked, especially for those with existing liver conditions.
Q: Can Lovaza be used alongside other blood pressure medications?
A: Certain types of blood pressure medicines, including drug classes such as beta blockers and thiazides (water pills), are known to potentially worsen high triglyceride levels. Regulatory guidance states that these medications should be discontinued or changed, if possible, before initiating Lovaza treatment.
Q: What kind of studies support the use of Lovaza in combination therapy?
A: The medication has been studied in combination with other lipid-lowering agents, such as statin medicines. These studies found no clinically significant drug-drug interactions resulting from the inhibition of major liver enzymes. Lovaza is also formally indicated to be used in combination with a dedicated diet.
Q: Why is the dosage of Lovaza often four capsules a day?
A: The daily dosage established through clinical trials is based on the therapeutic amount of the active ingredient. Since each capsule contains a specific quantity, this results in the prescribed number of capsules for the effective daily dose.
Q: Are there non-drug ingredients in Lovaza capsules I should know about?
A: Yes, official product documents list the non-drug, or inactive, ingredients that make up the capsule. These include the shell components (gelatin, glycerol, purified water) and an added antioxidant, alpha-tocopherol (a form of Vitamin E), which is contained in soybean oil.
Q: What is the purpose of the Vitamin E listed in the ingredients of Lovaza?
A: The ingredient alpha-tocopherol is a form of Vitamin E. This inactive component is included to function as an antioxidant, helping to preserve the stability of the medication.
Q: Can Lovaza cause dizziness or lightheadedness?
A: Dizziness is listed among the serious side effects that have been reported in postmarketing experience. However, it is not classified as one of the most common reactions observed in initial clinical trials, and its exact frequency is not known.
Q: Is Lovaza known to cause fatigue?
A: Official safety information includes unusual tiredness or weakness among the side effects reported outside of comparative clinical trials. Similar to dizziness, it is not classified as a common reaction. If a patient experiences new or unusual effects, they should inform their prescribing healthcare provider.
Q: Why do official documents restrict who can use Lovaza?
A: Restrictions on who can use the medicine exist primarily because the safety and effectiveness have not been established in certain populations, like pediatric patients. Other restrictions relate to known hypersensitivities to the drug or its components. The official documents also note that the medication should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
